Drug Importation to India- A Regulatory Blueprint

India is one of the top pharmaceutical markets in the world. With population of more than 1.36 Billion, there is never-ending demand for medicinal products. Hence, the chances of medicinal product success are excellent in India. The government of India is now actively indulging in raising the Regulatory standards and expansion of foreign investments, which makes the regulations and the approval processes more dynamic. Thus, to successfully import a drug in India, one must have detailed knowledge about the laws & requirements, submissions and approvals. If you are a drug manufacturer aspiring to enter the Indian pharma market and looking for a deep understanding of the regulations, Freyr has got you covered with a comprehensive webinar on “Drug Importation to India- A Regulatory Blueprint.” Our experts – Dr Ghulam Moinuddin and Michael Lambell will take you through the current scenario of the Indian pharma market and the breakdowns in approval procedure. Join us for the insightful session on June 17, 2021 at 10:00 AM CDT | 11:00 AM EDT | 4:00 PM BST | 5:00 PM CEST.